Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antithrombotic Treatment After IntraCerebral Haemorrhage (STATICH)
NCT03186729Phase 4Terminated
- Sponsor
- Oslo University Hospital
- Start
- Jul 2018
- Primary completion
- Aug 2024
- Countries
- 3
01
Overview
Phase 4, randomised, open-label trial in ischemia (2 arms), sponsored by Oslo University Hospital. Primary endpoint: Fatal or non-fatal symptomatic intracerebral haemorrhage at 2 years. Started Jul 2018; status: terminated.
02
Conditions
ischemia
Beyond the preview
Go deeper on NCT03186729.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03186729.